Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19
Eamon Conway, Camelia Walker, Michael Lydeamore, Nick Golding, Gerard Ryan, Dario Mavec, James Oates, Greg Kabashima, David J Price, Freya Shearer, Deborah Cromer, Miles P Davenport, James McCaw, Emily M Eriksson, Philip D Hodgkin, Logan Wu, Thao P. Le, Christopher M. Baker, Ivo Mueller, Jodie McVernon
doi: https://doi.org/10.1101/2024.05.14.24307386
Eamon Conway
1Population Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia
Camelia Walker
2School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria 3010, Australia
Michael Lydeamore
3Department of Econometrics and Business Statistics, Monash University, Melbourne, Victoria 3800, Australia
Nick Golding
6Telethon Kids Institute, Nedlands, Western Australia 6009, Australia
Gerard Ryan
4Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia
6Telethon Kids Institute, Nedlands, Western Australia 6009, Australia
Dario Mavec
8Quantium, Sydney, New South Wales, Australia
James Oates
8Quantium, Sydney, New South Wales, Australia
Greg Kabashima
8Quantium, Sydney, New South Wales, Australia
David J Price
4Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia
5Department of Infectious Diseases at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3010, Australia
Freya Shearer
4Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia
Deborah Cromer
7Kirby Institute, University of New South Wales, Sydney, New South Wales 2052, Australia
Miles P Davenport
7Kirby Institute, University of New South Wales, Sydney, New South Wales 2052, Australia
James McCaw
2School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria 3010, Australia
Emily M Eriksson
1Population Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia
Philip D Hodgkin
11Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia
Logan Wu
1Population Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia
Thao P. Le
2School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria 3010, Australia
9Melbourne Centre for Data Science, The University of Melbourne, Melbourne, Victoria 3010, Australia
10Centre of Excellence for Biosecurity Risk Analysis, The University of Melbourne, Melbourne, Victoria 3010, Australia
Christopher M. Baker
2School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria 3010, Australia
9Melbourne Centre for Data Science, The University of Melbourne, Melbourne, Victoria 3010, Australia
10Centre of Excellence for Biosecurity Risk Analysis, The University of Melbourne, Melbourne, Victoria 3010, Australia
Ivo Mueller
1Population Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia
Jodie McVernon
5Department of Infectious Diseases at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3010, Australia
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted May 15, 2024.
Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19
Eamon Conway, Camelia Walker, Michael Lydeamore, Nick Golding, Gerard Ryan, Dario Mavec, James Oates, Greg Kabashima, David J Price, Freya Shearer, Deborah Cromer, Miles P Davenport, James McCaw, Emily M Eriksson, Philip D Hodgkin, Logan Wu, Thao P. Le, Christopher M. Baker, Ivo Mueller, Jodie McVernon
medRxiv 2024.05.14.24307386; doi: https://doi.org/10.1101/2024.05.14.24307386
Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19
Eamon Conway, Camelia Walker, Michael Lydeamore, Nick Golding, Gerard Ryan, Dario Mavec, James Oates, Greg Kabashima, David J Price, Freya Shearer, Deborah Cromer, Miles P Davenport, James McCaw, Emily M Eriksson, Philip D Hodgkin, Logan Wu, Thao P. Le, Christopher M. Baker, Ivo Mueller, Jodie McVernon
medRxiv 2024.05.14.24307386; doi: https://doi.org/10.1101/2024.05.14.24307386
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12630)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (411)
- Health Economics (717)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2230)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)